SCHEMBL7624337

SCHEMBL7624337

O=C(O)N(CC(c1ccccc1)c1ccccc1)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.47
GLA P06280 2/20 0.47
TSHR P16473 2/20 0.47
HTR2A P28223 1/20 0.47
HRH1 P35367 1/20 0.47
TDP1 Q9NUW8 1/20 0.45
SMN1; SMN2 Q16637 2/20 0.44
HTT P42858 2/20 0.44
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
PAX8 Q06710 1/20 0.44
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
TP53 P04637 1/20 0.42
GAA P10253 1/20 0.41
NPSR1 Q6W5P4 1/20 0.40
CYP2D6 P10635 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28986139 0.83 AOC3 (0.50) ALDH1A1GLATSHRSMN1; SMN2HTT
SCHEMBL9853036 0.81 HRH1 (0.50) ALDH1A1GLATSHRHTR2AHRH1
SCHEMBL11404737 0.80 ALDH1A1 (0.52) ALDH1A1GLATSHRSMN1; SMN2HTT
SCHEMBL2087151 0.78 LMNA (0.43) ALDH1A1GLATSHRHTR2AHRH1
SCHEMBL9160381 0.76 ALDH1A1 (0.56) ALDH1A1GLATSHRSMN1; SMN2HTT
SCHEMBL9756803 0.76 ALDH1A1 (0.47) ALDH1A1GLATSHRTDP1SMN1; SMN2
SCHEMBL11790236 0.76 ALDH1A1 (0.47) ALDH1A1GLATSHRSMN1; SMN2HTT
SCHEMBL9756801 0.76 ALDH1A1 (0.47) ALDH1A1GLATSHRTDP1SMN1; SMN2
SCHEMBL9629108 0.76 ALDH1A1 (0.49) ALDH1A1GLATSHRSMN1; SMN2HTT
SCHEMBL2065480 0.75 HTR2A (0.50) HTR2AHRH1TDP1CYP2D6SRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020019389-A1 Urea derivative useful as an anti-cancer agent and process for preparing same CHACONNE NSI CO., LTD. (KR) 2002-02-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020019389-A1 Urea derivative useful as an anti-cancer agent and process for preparing same UTS2R, SLC14A1, URB2 ALDH1A1 2872/4885GLA 2240/4885TSHR 4795/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.